Cue Biopharma, Inc.CUENASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank50
3Y CAGR+24.9%
5Y CAGR-2.0%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+24.9%/yr
vs -20.6%/yr prior
5Y CAGR
-2.0%/yr
Recent acceleration
Acceleration
+45.5pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $419000.00 | -49.3% |
| 2024 | $826000.00 | -41.7% |
| 2023 | $1.42M | +558.6% |
| 2022 | $215000.00 | +368.4% |
| 2021 | $45898.00 | -90.1% |
| 2020 | $463914.00 | -3.9% |
| 2019 | $482790.00 | -10.8% |
| 2018 | $541345.00 | +1546600.0% |
| 2017 | $35.00 | -32.7% |
| 2016 | $52.00 | - |